Disc Medicine, Inc.
IRON
株式のランク
#4958
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
株価
$75.39
最終同期: 2026-10-22
時価総額
$2.89B
変化（1日）
-0.80%
変化（1年）
-9.92%
国
US
取引 Disc Medicine, Inc. (IRON)
カテゴリー
Healthcare
Disc Medicine, Inc.（IRON）のEPS
June 2026 時点のEPS TTM: $-6.60
Disc Medicine, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は$-6.60です。2024年末には、EPSは$-3.96で、2023年のEPS$-3.42と増加でした。
Disc Medicine, Inc.のEPS履歴（2020から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $-6.60 | 9.82% |
| 2025 | $-6.01 | 51.77% |
| 2024 | $-3.96 | 15.79% |
| 2023 | $-3.42 | -92.41% |
| 2022 | $-45.05 | 0.38% |
| 2021 | $-44.88 | 66.10% |
| 2020 | $-27.02 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| $17.32 | -362.42% |
US
|
|
| $-7.98 | 20.91% |
US
|
|
| $-5.29 | -19.85% |
AU
|
|
| $12.97 | -296.53% |
BE
|
|
| $27.74 | -520.30% |
NL
|
